Nob Hill Therapeutics has developed a first of its kind dry powder nebulizer (DryNebTM) inhalation drug delivery platform. Nob Hill is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases. DryNeb can change how lung-related diseases are treated. The DryNeb is the world’s first and only inhalation device that can be combined with a therapeutic to deliver high doses of medicine directly to the lungs in a short period of time while a patient breathes normally.
